RAP 0.00% 20.5¢ raptor resources limited

Ann: Trading Halt, page-263

  1. 644 Posts.
    lightbulb Created with Sketch. 81
    In our current landscape, this announcement is likely an update to shareholders on a new regulatory approval pathway we have applied for.

    The unknown is how this relates to Sanofi. The timing of the announcement is aligns to the expiry of Sanofi's option to continue with our collaboration effort. Perhaps management thought it would be best to amend our FDA approval submission to include the direct to consumer application of our tech.

    Expect the unexpected
    Last edited by showie: 11/03/20
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.